Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Nanomedicine (Lond). 2011 Jan;6(1):25–42. doi: 10.2217/nnm.10.129

Table 5.

Preservation of catalase enzymatic activity in BIC by EPRa, b

Formulation Z ratio Incubation time
50 min 100 min 150 min
Catalase alonec 0 35.1 ± 2 6.8 ± 1 3.1 ± 0.1

PEI50-PEG/catalase 1 47.4 ± 1 (ns) 33.7 ± 1 (**) 15.8 ± 3 (**)
10 67.5 ± 4 (**) 78.9 ± 8 (**) 77.2 ± 6 (**)
20 68.9 ± 3 (**) 88.4 ± 3 (**) 81.4 ± 4 (**)

PL10-PEG/catalase 1 68.2 ± 4 (*) 61.4 ± 3 (**) 57.7 ± 4 (**)
10 88.2 ± 2 (**) 89.9 ± 3 (**) 79.0 ± 3 (**)
20 93.9 ± 6 (**) 97.4 ± 8 (**) 91.5 ± 5 (**)

PGLU50-PEG/catalase 1 49.5 ± 2 (ns) 46.0 ± 3 (**) 57.9 ± 4 (**)
10 85.8 ± 4 (**) 82.1± 3 (**) 78.4 ± 3 (**)
20 97.8 ± 5 (**) 91.2 ± 8 (**) 80.1 ± 3 (**)
a

Activity of each nanozyme is expressed as a % of residual catalase activity vs. initial activity at 0 time point

b

Statistical significance is shown by asterisk: p<0.05 (*), and p<0.005 (**) compared with residual activity of catalase alone at the same time point.

c

Catalase concentration was 250 ng/mL